Medtronic (MDT) announced the broad U.S. commercial launch of the MiniMed 780G system integrated with the Instinct sensor, made by Abbott and designed exclusively for MiniMed systems. Following U.S. FDA clearance of the system earlier this year to enable integration with the Instinct sensor, the system is now shipping to customers across the U.S., marking a major milestone in diabetes technology and delivering a smart, seamless way to manage diabetes.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDT:
- Teva, Amgen, Rithm, Fastly, Medtronic: Major Stock Moves!
- QuantumScape, Medtronic, MP Materials, Canadian Solar, AeroVironment: Trending by Analysts
- Medtronic price target raised to $110 from $103 at Truist
- Medtronic price target raised to $111 from $109 at Barclays
- DoorDash, Baidu upgraded: Wall Street’s top analyst calls